Fig. 3

Survival outcomes of type O recipients: comparison between the IgM-only and IgG monitoring periods. Graft survival (A) was similar between the two periods, while AR-free (B) and ABMR-free (C) survival were significantly improved during the IgG monitoring period (P = 0.037 and P = 0.041, respectively).